Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Akebia Therapeutics (AKBA)

Akebia Therapeutics (AKBA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Clovis Oncology is Among the Companies in the Biotechnology Industry with the Best Relative Performance (CLVS , AKBA , SAGE , FPRX , AGIO )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AKBA : 8.32 (+4.92%)
CLVS : 9.14 (-2.25%)
SAGE : 71.84 (-1.95%)
Relatively Good Performance Detected in Shares of Akebia Therapeut in the Biotechnology Industry (AKBA , FOLD , NVTA , BPMC , CTMX )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AKBA : 8.32 (+4.92%)
FOLD : 9.69 (-0.97%)
NVTA : 18.75 (unch)
Akebia Therapeut Has Returned 57.5% Since SmarTrend Recommendation (AKBA)

SmarTrend identified an Uptrend for Akebia Therapeut (NASDAQ:AKBA) on November 25th, 2019 at $4.54. In approximately 2 months, Akebia Therapeut has returned 57.49% as of today's recent price of $7.15....

AKBA : 8.32 (+4.92%)
Shares of AKBA Up 45.8% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Akebia Therapeut (NASDAQ:AKBA) on November 25th, 2019 at $4.54. In approximately 1 month, Akebia Therapeut has returned 45.81% as of today's recent price of $6.62.

AKBA : 8.32 (+4.92%)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted six newly-hired employees...

AKBA : 8.32 (+4.92%)
Relatively Good Performance Detected in Shares of Epizyme Inc in the Biotechnology Industry (EPZM , AIMT , AKBA , ARWR, ATRA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AIMT : 33.22 (+0.44%)
AKBA : 8.32 (+4.92%)
EPZM : 25.51 (-1.94%)
ARWR : 47.58 (-0.02%)
SmarTrend Watching for Potential Pullback in Shares of Akebia Therapeut After 2.02% Gain

Akebia Therapeut (NASDAQ:AKBA) traded in a range yesterday that spanned from a low of $6.61 to a high of $6.90. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of...

AKBA : 8.32 (+4.92%)
Uptrend Call Working As Akebia Therapeut Stock Rises 45.2% (AKBA)

SmarTrend identified an Uptrend for Akebia Therapeut (NASDAQ:AKBA) on November 25th, 2019 at $4.54. In approximately 4 weeks, Akebia Therapeut has returned 45.15% as of today's recent price of $6.59.

AKBA : 8.32 (+4.92%)
40.7% Return Seen to Date on SmarTrend Akebia Therapeut Call (AKBA)

SmarTrend identified an Uptrend for Akebia Therapeut (NASDAQ:AKBA) on November 25th, 2019 at $4.54. In approximately 3 weeks, Akebia Therapeut has returned 40.75% as of today's recent price of $6.39.

AKBA : 8.32 (+4.92%)
Akebia Therapeut (AKBA)

SmarTrend identified a Downtrend for Akebia Therapeut (NASDAQ:AKBA) on September 30th, 2019 at $4.03. In approximately 2 months, Akebia Therapeut has returned 46.65% as of today's recent price of $5.91....

AKBA : 8.32 (+4.92%)
Arrowhead Pharma has the Best Relative Performance in the Biotechnology Industry (ARWR, AKBA , SGMO , BLUE , CCXI )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

AKBA : 8.32 (+4.92%)
SGMO : 8.19 (-0.85%)
ARWR : 47.58 (-0.02%)
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, granted 14 newly-hired employees...

AKBA : 8.32 (+4.92%)
Options Traders Expect Huge Moves in Akebia Therapeutics (AKBA) Stock

Investors need to pay close attention to Akebia Therapeutics (AKBA) stock based on the movements in the options market lately.

AKBA : 8.32 (+4.92%)
Akebia Therapeut has the Best Relative Performance in the Biotechnology Industry (AKBA , BPMC , ADMS , ARWR, FGEN )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ADMS : 5.88 (-1.51%)
AKBA : 8.32 (+4.92%)
BPMC : 69.82 (-12.44%)
ARWR : 47.58 (-0.02%)
Look for Shares of Akebia Therapeut to Potentially Pullback after Yesterday's 11.52% Rise

Akebia Therapeut (NASDAQ:AKBA) traded in a range yesterday that spanned from a low of $5.53 to a high of $6.56. Yesterday, the shares gained 11.5%, which took the trading range above the 3-day high of...

AKBA : 8.32 (+4.92%)
Akebia Therapeutics to Present at Upcoming Investor Conferences

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced its executives...

AKBA : 8.32 (+4.92%)
Watch for Akebia Therapeut to Potentially Pullback After Gaining 8.49% Yesterday

Akebia Therapeut (NASDAQ:AKBA) traded in a range yesterday that spanned from a low of $3.17 to a high of $3.65. Yesterday, the shares gained 8.5%, which took the trading range above the 3-day high of...

AKBA : 8.32 (+4.92%)
Look for Shares of Akebia Therapeut to Potentially Rebound after Yesterday's 7.96% Sell Off

Akebia Therapeut (NASDAQ:AKBA) traded in a range yesterday that spanned from a low of $2.99 to a high of $3.30. Yesterday, the shares fell 8.0%, which took the trading range below the 3-day low of $3.23...

AKBA : 8.32 (+4.92%)
Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates

Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 24.32% and -2.09%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

AKBA : 8.32 (+4.92%)
Akebia Therapeutics: 3Q Earnings Snapshot

CAMBRIDGE, Mass. (AP) _ Akebia Therapeutics Inc. (AKBA) on Tuesday reported a loss of $54.6 million in its third quarter.

AKBA : 8.32 (+4.92%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS +0.44 , SEDG +0.93 , THC +0.25 , TER +2.04 , LITE +0.76
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar